Skip Navigation

Cardiovascular Research 1997 34(2):323-328; doi:10.1016/S0008-6363(97)00002-3
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ino, T.
Right arrow Articles by Okada, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ino, T.
Right arrow Articles by Okada, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Late, persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis

Toshihiro Inoa,*, Masahiko Kishiroa, Mataichi Okuboa, Katsumi Akimotoa, Kei Nishimotoa, Keijiro Yabutaa and Ryozo Okadab

aDepartment of Pediatrics, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113, Japan
bCardiovascular Pathology Laboratory, Juntendo University School of Medicine, 2-1-1- Hongo, Bunkyo-ku, Tokyo 113, Japan

* Corresponding author. Fax +81 3 5800-0216.

Background: Both intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) have been implicated in cardiac allograft rejection. However, there is little information about the relationship between the expression of these adhesion molecules and myocarditis in children. Methods and Results: Immunoreactivities of ICAM-1 and VCAM-1 were examined by enzyme immunoassay in 31 biopsy specimens obtained from 11 pediatric patients with biopsy-proven myocarditis or cardiomyopathy. Five of the 11 patients had clear evidence of acute myocarditis. The other 6 had ECG abnormalities identified by mass screening for heart disease, and subsequently had been histologically diagnosed as having non-specific cardiomyopathy. The period between onset of myocarditis or identification of ECG abnormality and immunohistochemical studies was 23 to 60 days and 8 months to 3 years, respectively. Expression of ICAM-1 and VCAM-1 was assessed by counting ICAM-1- and VCAM-1-positive vessels and dividing by the total number of vessels. ICAM-1 was significantly present on 81% (P<0.01) of myocardial tissue samples in the 5 patients with healing-stage acute myocarditis, and on 45% (P<0.05) in the remaining 6 patients with non-specific cardiomyopathy, compared with 24% in control specimens obtained from right ventricular muscle resected at surgery for tetralogy of Fallot. VCAM-1 was also present on 50% (P<0.05) of the samples from the 5 patients with acute myocarditis, but was not present in those with non-specific cardiomyopathy. Conclusion: This persistent expression of ICAM-1 suggests that myocardial cell damage may persist immunologically for a long period in myocarditis. In addition, immunostaining for these adhesion molecules may be of diagnostic value in clinically silent lymphocytic myocarditis and chronic cardiomyopathy.

KEYWORDS Myocarditis; ICAM-1; VCAM-1; Cardiomyopathy; Human


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
H. N. Skouri, G. W. Dec, M. G. Friedrich, and L. T. Cooper
Noninvasive Imaging in Myocarditis
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 2085 - 2093.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl
Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy
Eur J Heart Fail, August 1, 2003; 5(4): 469 - 479.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. Noutsias, M. Pauschinger, H.-P. Schultheiss, and U. Kuhl
Advances in the immunohistological diagnosis of inflammatory cardiomyopathy
Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I54 - I62.
[Abstract] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. L. Graciano, D. D. Bryant, D. J. White, J. Horton, N. E. Bowles, and B. P. Giroir
Targeted disruption of ICAM-1, P-selectin genes improves cardiac function and survival in TNF-{alpha} transgenic mice
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1464 - H1471.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Noutsias, B. Seeberg, H.-P. Schultheiss, and U. Kuhl
Expression of Cell Adhesion Molecules in Dilated Cardiomyopathy : Evidence for Endothelial Activation in Inflammatory Cardiomyopathy
Circulation, April 27, 1999; 99(16): 2124 - 2131.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.